" class="no-js "lang="en-US"> Koenraad Batselier - Medtech Alert
Monday, August 18, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Koenraad Batselier

Koenraad Batselier

About Koenraad Batselier

Experienced Executive in Healthcare IT

Business Development, Sales, Service and Operations Management experience.

Specialties: Sales leadership, business and product management, professional services, project management skills, negotiation skills, IT integration & implementation skills, services business integrations (mergers and acquisition projects)

Related Story

Industry News

 ObvioHealth Expands Digital Health Research Ecosystem Through New Global Licensing Agreement With Dedalus | Pharmtech Focus

ObvioHealth Expands Digital Health Research Ecosystem Through New Global Licensing Agreement With Dedalus

June 28 2022

ObvioHealth, a global virtual research organization (VRO), extends its strategic alliance with Dedalus Group (“Dedalus”), […]